228 related articles for article (PubMed ID: 15364150)
21. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW;
J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247
[TBL] [Abstract][Full Text] [Related]
23. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
24. Valuing the benefits of a health intervention using three different approaches to contingent valuation: re-treatment of mosquito bed-nets in Nigeria.
Onwujekwe O; Fox-Rushby J; Hanson K
J Health Serv Res Policy; 2004 Apr; 9(2):67-75. PubMed ID: 15099453
[TBL] [Abstract][Full Text] [Related]
25. Risk of restenosis and health status outcomes for patients undergoing percutaneous coronary intervention versus coronary artery bypass graft surgery.
Spertus JA; Nerella R; Kettlekamp R; House J; Marso S; Borkon AM; Rumsfeld JS
Circulation; 2005 Feb; 111(6):768-73. PubMed ID: 15699258
[TBL] [Abstract][Full Text] [Related]
26. Patients' willingness to pay for pharmacist-provided menopause and hormone replacement therapy consultations.
Barner JC; Branvold A
Res Social Adm Pharm; 2005 Mar; 1(1):77-100. PubMed ID: 17138467
[TBL] [Abstract][Full Text] [Related]
27. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
[TBL] [Abstract][Full Text] [Related]
28. Analysis of willingness to pay for implantable cardioverter-defibrillator therapy.
Nowakowska D; Guertin JR; Liu A; Abrahamowicz M; Lelorier J; Lespérance F; Brophy JM; Rinfret S
Am J Cardiol; 2011 Feb; 107(3):423-7. PubMed ID: 21257009
[TBL] [Abstract][Full Text] [Related]
29. Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients.
Billinger M; Beutler J; Taghetchian KR; Remondino A; Wenaweser P; Cook S; Togni M; Seiler C; Stettler C; Eberli FR; Lüscher TF; Wandel S; Jüni P; Meier B; Windecker S
Eur Heart J; 2008 Mar; 29(6):718-25. PubMed ID: 18272504
[TBL] [Abstract][Full Text] [Related]
30. Analysis of recurrent revascularization events following percutaneous coronary intervention of diabetic patients.
Anselmino M; Delcrè S; Moretti C; Biondi-Zoccai G; Omedè P; Sciuto F; Trevi GP; Sheiban I
Minerva Cardioangiol; 2009 Apr; 57(2):151-7. PubMed ID: 19274025
[TBL] [Abstract][Full Text] [Related]
31. The economic value of informal care: a study of informal caregivers' and patients' willingness to pay and willingness to accept for informal care.
van den Berg B; Bleichrodt H; Eeckhoudt L
Health Econ; 2005 Apr; 14(4):363-76. PubMed ID: 15744739
[TBL] [Abstract][Full Text] [Related]
32. Long-term clinical outcomes after bioabsorbable polymer- and durable polymer-based sirolimus-eluting stents implantation: two-year follow-up results from a large single-center database.
Liu HB; Xu B; Yang YJ; Wang Y; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Ma WH; Li JJ; Qiao SB; Chen JL; Li W; Gao RL
Chin Med J (Engl); 2009 Mar; 122(6):681-6. PubMed ID: 19323934
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous coronary intervention with drug-eluting stents in octogenarians: characteristics, clinical presentation, and outcomes.
Hassani SE; Wolfram RM; Kuchulakanti PK; Xue Z; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Weissman NJ; Waksman R
Catheter Cardiovasc Interv; 2006 Jul; 68(1):36-43. PubMed ID: 16764007
[TBL] [Abstract][Full Text] [Related]
34. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
[TBL] [Abstract][Full Text] [Related]
35. Cost-benefit of drug eluting stents--time for a reality check.
Ward MR
Heart Lung Circ; 2005 Jun; 14(2):74-7. PubMed ID: 16352257
[TBL] [Abstract][Full Text] [Related]
36. Alternative approaches to obtain optimal bid values in contingent valuation studies and to model protest zeros. Estimating the determinants of individuals' willingness to pay for home care services in day case surgery.
Dalmau-Matarrodona E
Health Econ; 2001 Mar; 10(2):101-18. PubMed ID: 11252042
[TBL] [Abstract][Full Text] [Related]
37. Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial.
Garot P; Lefèvre T; Savage M; Louvard Y; Bamlet WR; Willerson JT; Morice MC; Holmes DR
J Am Coll Cardiol; 2005 Aug; 46(4):606-12. PubMed ID: 16098423
[TBL] [Abstract][Full Text] [Related]
38. [What aspects are inefficient concerning percutaneous coronary intervention in Japan?: International cost-effectiveness comparisons].
Chino M; Sakamoto M; Sasaki T; Isshiki T
J Cardiol; 2004 Sep; 44(3):85-92. PubMed ID: 15500158
[TBL] [Abstract][Full Text] [Related]
39. Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation.
Canibus P; Faloia E; Piva T; Muçai A; Serenelli M; Perna GP; Boscaro M; Piva R
Metabolism; 2008 May; 57(5):593-7. PubMed ID: 18442619
[TBL] [Abstract][Full Text] [Related]
40. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
